Tus kws kho mob
P3-19 Updated Reimbursement Policy for Preventable Readmission: Medicare Advantage
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 02, 2019
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2001 - 2010 ntawm 4204
Tus kws kho mob
P59-20 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 03, 2020
Tus kws kho mob
P60-20 Lab Management CPT Codes added by the American Medical Association (AMA) and eviCore Healthcare Specialty Utilization Management (UM) Program Updates
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 03, 2020
Tus kws kho mob
P54-20 Documentation Requirements for Replacement Claims
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 03, 2020
Tus kws kho mob
2020 August Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 03, 2020
Tus kws kho mob
P62-20 CMS Decision on Acupuncture for Chronic Low Back Pain
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 03, 2020
Tus kws kho mob
QP66-20 Updates to Injectable Drug Authorization Requests
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 22, 2020
Tus kws kho mob
QP64-20 Medical Drug Update for New to Market Viltolarsen
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 22, 2020
Tus kws kho mob
QP68-20 MHCP Pharmacy Benefit Update - Eylea®, Iluvien®, Lucentis®, Ozurdex® ,Retisert™ and Yutiq®
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 22, 2020